Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
cannabinoids
Biotech
Mira seeks to buy Skny for obesity, smoking cessation asset
Mira is trying to buy Skny Pharmaceuticals in a deal that would give it control of a preclinical prospect and add $5 million to its bank balance.
Nick Paul Taylor
Mar 24, 2025 10:08am
Polyrizon pays $3M for license to SciSparc's CB2R agonist
Aug 19, 2024 5:27am
Novo Nordisk bets $1B on biotech buyout to grow obesity pipeline
Aug 10, 2023 6:30am
Fortrea inks deal with Incannex for sleep apnea drug trial
Jul 27, 2023 9:28am
Cannabinoid-focused drugmaker InMed backs away from H&W sector
Sep 9, 2022 7:45am
Anebulo drug reduces cannabinoid intoxication in phase 2 study
Jul 5, 2022 12:39pm
